News
For additional media information, contact:
Arthur J. Shannon, Vice President, Investor Relations and Communications
ajshannon@perrigo.com
269-686-1709 (direct)
269-673-9128 (fax)
Archive: 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002
2006
Perrigo Company Announces FDA Approval For Simvastatin Tablets
Dec 21, 2006
See Attachment
Perrigo Company Announces FDA Approval For Ciclopirox Topical Suspension
Dec 19, 2006
See Attachment
Perrigo Announces Approval of Dexel's OTC Omeprazole
Dec 18, 2006
See Attachment
Perrigo Company Announces Dividend Increase
Nov 10, 2006
See Attachment
Perrigo Launches Precautionary Recall
Nov 9, 2006
See Attachment
Perrigo Announces Voluntary Product Recall and Reaffirms Full Year Earnings
Nov 9, 2006
See Attachment
Perrigo Company First Quarter FY 07 Earnings Press Release
Oct 31, 2006
See Attachment
Perrigo Company Will Release First Quarter Fiscal 2007 Results on Oct 31
Oct 24, 2006
See Attachment
Joseph C. Papa Is New President And CEO At Perrigo Company
Oct 9, 2006
See Attachment
Perrigo Company Will Host Conference Call Introducing Joe Papa As President and Chief Executive Officer On October 10, 2006
Oct 3, 2006
See Attachment
Perrigo Receives Tentative Approval For Ciclopirox Topical Solution
Oct 2, 2006
See Attachment
Perrigo Announces Approval For Famotidine Tablets
Sept 25, 2006
See Attachment
Perrigo Announces Joseph C. Papa As New CEO; David T. Gibbons To Remain As Chairman
Sept 11, 2006
See Attachment
Perrigo Receives Tentative Approval For Clobetasol Propionate Foam
Sept 1, 2006
See Attachment
Perrigo Company Announces Quarterly Dividend
Aug 11, 2006
See Attachment
Perrigo Company Reports Fiscal Year 2006 Results
Aug 9, 2006
See Attachment
Perrigo Company To Market Terbinafine Hydrochloride Tablets
Aug 7, 2006
See Attachment
Perrigo Company Will Release Fiscal Year 2006 Results On August 9, 2006
Aug 1, 2006
See Attachment
P errigo Company Announces Judy Brown Assumes CFO Position
July 6, 2006
See Attachment
Perrigo Company To Market Amlodipine Besylate Tablets
June 29, 2006
See Attachment
Perrigo Company To Close Two Facilities, Employees Offered Opportunity To Transfer
June 27, 2006
See Attachment
Perrigo Company Receives FDA Approval To Market Coated Nicotine Gum
June 14, 2006
See Attachment
Perrigo Announces Participation in Dexcel's Filing For Generic Version of Prilosec OTC(R)
June 7, 2006
See Attachment
Perrigo Company Announces Quarterly Dividend
May 12, 2006
See Attachment
Perrigo Company To Present At Bank Of America 2006 Health Care Conference
May 10, 2006
See Attachment
Perrigo Acknowledges Barr Patent Challenge of NASACORT®
May 4, 2006
See Attachment
Perrigo Company Reports Third Quarter Fiscal 2006 Financial Results
Apr 27, 2006
See Attachment
Perrigo Company Will Release Third Quarter Fiscal 2006 Results On April 27, 2006
Apr 20, 2006
See Attachment
Perrigo Company Shareholder Rights Agreement Expires
Apr 11, 2006
See Attachment
Perrigo Company Announces Approval For Terconazole Suppositories
Mar 21, 2006
See Attachment
Perrigo Company Announces Approval For Ciclopirox Olamine Cream
Mar 7, 2006
See Attachment
CFO Announces Plans To Retire From Perrigo
Mar 2, 2006
See Attachment
Perrigo Company Announces Tentative Approval For Sertraline Hydrochloride Tablets
Feb 22, 2006
See Attachment
Perrigo Company Announces Appointment of New Board Member, Authorizes Extension of Share Repurchase
Feb 21, 2006
See Attachment
Perrigo Company Announces Quarterly Dividend
Feb 15, 2006
See Attachment
Perrigo Company Reports Second Quarter Fiscal 2006 Financial Results
Feb 2, 2006
See Attachment
Perrigo Company Receives FDA Approval To Market Nicotine Lozenges
Feb 2, 2006
See Attachment
Perrigo Company Announces FDA Approval for Desoximetasone Gel
Jan 10, 2006
See Attachment